New FDA Team Seeks To Spur Antibiotics Innovation

Law360, New York (September 24, 2012, 6:12 PM EDT) -- The U.S. Food and Drug Administration on Monday announced the creation of a new task force to look at incentives for drug companies to develop new antibiotics to battle increasingly drug-resistant pathogens, and to write guidelines required by the new user fee law.

The Antibacterial Drug Development Task Force, made up of 19 FDA scientists and clinicians, will be responsible for writing guidelines with the goal of getting new antibiotics onto the market, the FDA said.

The guidelines are required by provisions in the user fee...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.